Recombinant human granulocyte– colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial

Autor: Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D, Ahmed, A, Bass, C, Benderatik, R, Bhattacharya, R, Cheong, Y, Dawood, F, Granne, I, Gupta, P, Horne, A, Manda, P, Mohiyiddeen, L, Moore, J, Quenby, S, Rai, R, Shillito, J, Stewart, J, Truchanowicz, E, Dwyer, L, Small, R, Sharpe, L, Smith, A, Coomarasamy, A, Grp, RESPONSE Study

Publikováno v: Human Reproduction (Oxford, England)
Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D 2019, ' Recombinant human granulocyte-colony stimulating factor in women with unexplained recurrent pregnancy losses : A randomized clinical trial ', Human Reproduction, vol. 34, no. 3, pp. 424-432 . https://doi.org/10.1093/humrep/dey393
HUMAN REPRODUCTION

Study question Does administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) in the first trimester improve pregnancy outcomes, among women with a history of unexplained recurrent pregnancy loss? Summary answer rhG-CSF admi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28be5dbc70a779e2f322e57cd04257a
http://europepmc.org/articles/PMC6389865